We observed the time of presentation after acute stroke in an urban Chinese population to determine if early randomization of large numbers to acute treatment trials of stroke patients is possible in China. We studied 187 consecutive acute stroke patients presenting at our hospital. According to the medical records maintained in the hospital, we analyzed the time of presentation and assessed relationships between presentation time and stroke types using a χ2 test. We also analyzed the factors associated with early presentation. In 187 acute stroke patients, there were 125 ischemic strokes (67.8%) and 62 hemorrhagic strokes (32.2%). For all stroke types, 49.7% (93/187) of patients presented within 3 h of stroke onset, 65.8% (123/187) within 6 h, 71.1% (146/ 187) within 12 h, 82.9% (155/187) within 24h and 87.7% (164/187) within 48 h. For ischemic and hemorrhagic stroke, the time of hospital arrivals were 41.6 and 66.1% within 3 h of stroke onset, 60.0 and 77.4% within 6 h, 73.6 and 87.1% within 12 h, 77.7 and 93.5% within 24 h, 89.8 and 93.5% within 48 h, respectively. This urban Chinese stroke population seen at a university hospital showed a relatively early presentation after acute stroke onset and this observation should be evaluated in other Chinese stroke patient populations.

Keywords:
Stroke, Timing, China
This content is only available via PDF.
© 1995 S. Karger AG, Basel
1995
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.